Winthrop University Hospital
Mineola, New York, 11501, United States
NCT Number: NCT00762775
We will study the relative importance of high calcium intake and vitamin D supplementation for calcium homeostasis, as determined by serum parathyroid hormone (PTH) and biochemical bone markers. We also intend to examine the interaction of vitamin D and calcium intake on calcium homeostasis. We hypothesize that optimal calcium supplementation and optimal vitamin D supplementation will lead to lower serum levels of PTH and markers of bone resorption compared with the placebo. We also theorize that when taken together, optimal calcium supplementation and optimal vitamin D intake will result in lower serum levels of PTH and bone markers compared with calcium or vitamin D taken alone.
Looking for future studies?
Notify Me45 year–85 year
Female
Interventional
Not applicable
Mineola, New York, 11501, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Arm 1: 1,200 mg daily of calcium supplementation and placebo; Arm 2: 100 microgram daily of Vitamin D and placebo; Arm 3: 1,200 mg of calcium and 100 microgram of Vitamin D daily; Arm 4: placebos only.
Time frame: 6 months
Time frame: 6 months
Winthrop University Hospital
Other
Acronym: PTH Modified
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04815824
Aging, Behavior
Aurora, Colorado, United States
View Trial DetailsNCT02074631
Bone Diseases, Bone Diseases, Metabolic
Minneapolis, Minnesota, United States
View Trial DetailsNCT04403256
Bone Diseases, Bone Diseases, Metabolic
Daegu, South Korea
View Trial DetailsNCT00421408
Bone Diseases, Bone Diseases, Metabolic
Farmington, Connecticut, United States
View Trial Details